Yukio Takeshima
Hiroshima, 7348551, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.
Journal: Journal of neuro-oncology
Published: February 15, 2026
Rasmussen encephalitis without atrophy and increased 11C-methionine PET uptake mimicking glioma: A case report.
Journal: The neuroradiology journal
Published: December 20, 2025
Cortical Diffusion-Enhancement Mismatch Sign: A Specific Imaging Biomarker for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma.
Journal: Neurosurgery
Published: October 24, 2025
Merlin Immunohistochemistry Is Useful in the Differential Diagnosis of Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia.
Journal: Pathology international
Published: October 07, 2025
Combining Prostate-Specific Antigen Density With PI-RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion-Targeted Re-Biopsy.
Journal: The Prostate
Published: September 21, 2025
Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.
Journal: Japanese journal of clinical oncology
Published: July 16, 2025
Differences in clinical course between pituitary apoplexy and non-apoplexy patients with nonfunctioning pituitary neuroendocrine tumors.
Journal: Neurosurgical review
Published: June 26, 2025
Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant.
Journal: Journal of neuro-oncology
Published: October 31, 2024
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C.
Journal: Cell communication and signaling : CCS
Published: September 19, 2024
Role of guanylate-binding protein 1 in the proliferation of invasive lung adenocarcinoma cells.
Journal: Frontiers in oncology
Published: May 17, 2024
Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma.
Journal: Anticancer research
Published: May 14, 2024
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.
Journal: Journal of neuro-oncology
Published: May 06, 2024
Last Updated: 09/26/2026